Evidence-based imaging in lung cancer: a systematic review.
Lung cancer is the leading cause of cancer-related mortality in the United States. To assess prognosis, optimize treatment, and avoid potentially harmful futile treatments it is critical to have a complete understanding of the tumor's histology, molecular characteristics, and stage at the time of diagnosis. From the radiologist's perspective, the goal is to provide as accurate a stage as possible before the use of minimally invasive or invasive procedures to guide the site of biopsy and confirm a final pathologic stage. This article reviews the evidence behind the imaging technologies used in the staging evaluation of lung cancer.
Department of Radiology, Medical University of South Carolina, Charleston, SC 29425, USA. ravenejg@musc.edu
James G
JG
Ravenel
D001706:Biopsy; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology; D008279:Magnetic Resonance Imaging / Q000191:economics / Q000379:methods; D009367:Neoplasm Staging / Q000379:methods*; D049268:Positron-Emission Tomography / Q000191:economics / Q000379:methods; D011379:Prognosis; D055752:Small Cell Lung Carcinoma / Q000000981:diagnostic imaging / Q000473:pathology; D014057:Tomography, X-Ray Computed / Q000191:economics / Q000379:methods